help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kanazawa, H.
Right arrow Articles by Yoshikawa, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kanazawa, H.
Right arrow Articles by Yoshikawa, J.

Am. J. Respir. Crit. Care Med., Vol 155, No. 2, 02 1997, 747-750.

Synergistic effect of nitric oxide and vasoactive intestinal peptide on bronchoprotection against histamine in anesthetized guinea pigs

H Kanazawa, T Kawaguchi, S Shoji, T Fujii, S Kudoh, K Hirata, N Kurihara and J Yoshikawa
The First Department of Internal Medicine, Osaka City University Medical School, Japan.

Vasoactive intestinal peptide (VIP) and nitric oxide (NO) are considered to be nonadrenergic, noncholinergic (NANC) inhibitory neurostransmitters in the airways. It seems likely that these neurotransmitters may be coreleased and act as functional antagonists against bronchoconstrictor stimuli. In the present study, we examined the synergistic effect of NO and VIP on bronchoprotection against histamine in anesthetized guinea pigs. The NO donor, S-nitroso-N- acetylpenicillamine (SNAP) significantly inhibited histamine-induced bronchoconstriction in a dose-dependent manner. VIP also inhibited histamine-induced bronchoconstriction in a dose-dependent manner, but this bronchoprotective effect was short-lived. Additionally, VIP (10(- 9) M) had no significant bronchoprotective effect, but a subthreshold dose of SNAP (10(-7) M) significantly potentiated VIP (10(-9) M)- induced bronchoprotection against histamine. Moreover, SNAP (10(-7) M) significantly enhanced VIP (10(-7) M)-induced bronchoprotection for a longer period of time. On the other hand, VIP (10(-9) M) also significantly potentiated SNAP-induced bronchoprotection against histamine. In conclusion, combination therapy with NO donor and VIP receptor agonist may have important advantages in the treatment of bronchial asthma, and both NO and VIP may contribute in complementary fashion to the NANC-induced relaxant response in guinea pig airways.


This article has been cited by other articles:


Home page
 J. Appl. Physiol.Home page
B. W. Wilkins, L. H. Chung, N. J. Tublitz, B. J. Wong, and C. T. Minson
Mechanisms of vasoactive intestinal peptide-mediated vasodilation in human skin
J Appl Physiol, October 1, 2004; 97(4): 1291 - 1298.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
H. KANAZAWA, S. SHIRAISHI, T. OKAMOTO, K. HIRATA, and J. YOSHIKAWA
Inhibition of Bronchoprotective Effects of beta 2-Adrenoceptor Agonists by Peroxynitrite in Guinea Pig Airways
Am. J. Respir. Crit. Care Med., April 1, 1999; 159(4): 1272 - 1276.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
H. KANAZAWA, K. HIRATA, and J. YOSHIKAWA
Guinea Pig Airway Hyperresponsiveness Induced by Blockade of the Angiotensin II Type 1 Receptor . Role for Endogenous Nitric Oxide
Am. J. Respir. Crit. Care Med., January 1, 1999; 159(1): 165 - 168.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 1997 American Thoracic Society